Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis
Lisa A. Beck, Michael J. Cork, Masayuki Amagai, Anna De Benedetto, Kenji Kabashima, Jennifer D. Hamilton, Ana B. Rossi
Abstract
skin colonization. Systemic anti‒type 2 inflammation therapies may improve dysfunctional skin barrier in AD.
Topics & Concepts
Atopic dermatitisSkin barrierDermatologyInflammationMedicineImmunologyDermatology and Skin DiseasesFood Allergy and Anaphylaxis ResearchExercise and Physiological Responses